Concepedia

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece

Αrgyris Τzouvelekis, Τheodoros Karampitsakos, Georgia Gomatou, Evangelos Bouros, Vasilios Tzilas, E. Manali, Ioannis Tomos, Athina Trachalaki, Lykourgos Kolilekas, Ioanna Korbila,

Pulmonary Pharmacology & Therapeutics · 2019 · 54 citations · 29 references

DOI

Concepts

References

29

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu, Harold R. Collard, Jim Egan et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 7.3K citations · Full text

, , +17

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

, , +13

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

, , +13

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck, R. Kaiser, Anders Mellemgaard et al. · The Lancet Oncology · 2014 · 948 citations · Full text

, , +11

Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study

Richard Hubbard, Andrea Venn, Sarah Lewis et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 641 citations

, , +15